Atlas Trials

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Clinical trial NCT01382095 · COMPLETED

Trial details

NCT number
NCT01382095
Sponsor
U.S. Army Medical Research and Development Command
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Escherichia Coli Infection
Start date
2011-07-01
Primary completion
2012-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.